Responses
General and risk management, patient safety
GRP-041 Collection and Analysis of Adverse Effects and Co-Medications For Outpatients Receiving Boceprevir- or Telaprevir-Based Treatment For Chronic Hepatitis C
Compose a Response to This Article
Other responses
No responses have been published for this article.